Medicare Enrolled
Dr. Justin Weiner, DO
Critical Care Medicine · Palos Heights, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Weiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weiner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Weiner
Dr. Justin Weiner is a critical care medicine specialist in Palos Heights, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Weiner performed 1,555 Medicare services across 1,261 unique beneficiaries.
Between the years covered by Open Payments, Dr. Weiner received a total of $14,470 from 39 pharmaceutical and/or device companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Weiner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 24% volume in IL
$14,470 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,555
Medicare services
Top 24% in IL for critical care medicine
1,261
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
378 | $108 | $344 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $77 | $247 |
| Levalbuterol inhalation solution, 0.5 mg A 0.5 mg unit dose of FDA-approved levalbuterol inhalation solution administered via durable medical equipment. |
142 | $0 | $5 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
140 | $16 | $76 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
136 | $30 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
131 | $143 | $416 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
90 | $48 | $268 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
76 | $24 | $148 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
59 | $66 | $145 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
52 | $45 | $219 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
39 | $88 | $297 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
36 | $100 | $209 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $154 | $349 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
21 | $8 | $29 |
| New patient office visit, complex (60-74 min) | 17 | $184 | $384 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
14 | $16 | $43 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $75 | $394 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
14 | $70 | $283 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $145 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,470
Total received (2018-2024)
Avg $2,067/year across 7 years
Top 12% in IL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
629
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,390 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$550
2023
$1,903
2022
$4,053
2021
$2,924
2020
$1,953
2019
$2,922
2018
$164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$289
GlaxoSmithKline, LLC.
$156
Axsome Therapeutics, Inc.
$51
AstraZeneca Pharmaceuticals LP
$29
Actelion Pharmaceuticals US, Inc.
$25
Top 3 companies account for 90.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,779
AstraZeneca Pharmaceuticals LP
$1,624
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,225
Regeneron Healthcare Solutions, Inc.
$926
Mylan Specialty L.P.
$796
GENZYME CORPORATION
$712
Insmed, Inc.
$568
Actelion Pharmaceuticals US, Inc.
$541
Amgen Inc.
$505
Harmony Biosciences LLC
$389
Sunovion Pharmaceuticals Inc.
$355
Philips Electronics North America Corporation
$338
Electromed, Inc.
$319
Genentech USA, Inc.
$276
Eisai Inc.
$206
JAZZ PHARMACEUTICALS INC.
$191
Mallinckrodt Hospital Products Inc.
$186
Advanced Respiratory, Inc
$176
Olympus America Inc.
$125
Merck Sharp & Dohme LLC
$111
ADVANCED RESPIRATORY, INC
$105
Baxter Healthcare
$98
EISAI INC.
$88
Teva Pharmaceuticals USA, Inc.
$85
SANOFI-AVENTIS U.S. LLC
$80
Merck Sharp & Dohme Corporation
$77
Takeda Pharmaceuticals U.S.A., Inc.
$73
Circassia Pharmaceuticals Inc
$73
Bayer HealthCare Pharmaceuticals Inc.
$67
HARMONY BIOSCIENCES LLC
$58
Axsome Therapeutics, Inc.
$51
Grifols USA, LLC
$50
Novartis Pharmaceuticals Corporation
$42
Shire North American Group Inc
$40
Medtronic USA, Inc.
$36
Apria Healthcare LLC
$34
PFIZER INC.
$28
Phadia US Inc.
$21
Foundation Medicine, Inc.
$14
Top 3 companies account for 45.8% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ASMANEX · Adempas · Arikayce · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · DreamWear Pillows · Esbriet · FARXIGA · FASENRA · FOUNDATIONONE · GLASSIA · Hillrom - Life 2000 Ventilation System · INTELLIS · ImmunoCAP · LONHALA MAGNAIR · Medela · NUCALA · OFEV · OPSUMIT · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · UPTRAVI · UTIBRON NEOHALER · VERQUVO · WAKIX · Wakix · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
171
Per 100K population
3.3
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Weiner is a clinical cardiology specialist, with above-average Medicare volume (top 24% in IL), with low-engagement industry engagement in the top 12% of IL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Weiner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Weiner performed 378 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weiner receive payments from pharmaceutical companies?
Yes. Dr. Weiner received a total of $14,470 from 39 companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weiner's costs compare to other critical care medicines in Palos Heights?
Dr. Weiner's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Palos Heights
Browse critical care medicines in Palos Heights ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in IL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in IL
Which IL critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology